Myocardial oxidative metabolism in hyperthyroid patients assessed by PET with carbon-11-acetate

J Nucl Med. 1995 Nov;36(11):1981-6.

Abstract

Hyperthyroid patients often complain of cardiovascular symptoms because of increased metabolism. This study was designed to quantitatively evaluate myocardial oxidative metabolism in these patients.

Methods: Dynamic PET with 11C-acetate was performed in 19 patients who had not undergone treatment for hyperthyroidism. Eight were restudied 2 wk after oral administration of propranolol. The clearance rate constant of 11C-acetate (Kmono) was calculated with monoexponential fitting of tracer washout from the myocardium as a marker of myocardial oxidative metabolism. The results were compared with those in nine normal subjects both at rest and during dobutamine infusion.

Results: Kmono in our patients (0.109 +/- 0.028 min-1) was significantly increased compared to normal subjects (0.066 +/- 0.016 min-1) (p < 0.05). After propranolol treatment, Kmono decreased (0.082 +/- 0.014 min-1) but remained significantly higher in eight patients than normal subject levels (p < 0.05), while the rate pressure product decreased significantly (7500 +/- 1700) toward the normal range (7900 +/- 1500).

Conclusion: These results suggest the possibility of excessive myocardial oxygen consumption in hyperthyroid patients. The clearance rate of 11C-acetate is a new and valuable index to assess myocardial oxidative metabolism not closely related to the pressure rate product or thyroid hormones in these patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates*
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Carbon Radioisotopes*
  • Case-Control Studies
  • Female
  • Graves Disease / diagnostic imaging
  • Graves Disease / drug therapy
  • Graves Disease / metabolism*
  • Heart / diagnostic imaging*
  • Hemodynamics / physiology
  • Humans
  • Male
  • Myocardium / metabolism*
  • Oxygen Consumption / physiology*
  • Propranolol / therapeutic use
  • Thyroid Hormones / blood
  • Tomography, Emission-Computed*

Substances

  • Acetates
  • Adrenergic beta-Antagonists
  • Carbon Radioisotopes
  • Thyroid Hormones
  • Propranolol